Learn how to become an MFN Member
Login
Join MFN

Dr Martin Alexander

Gershon

Dr. Martin Alexander Gershon, MD, JD, MPH is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds and Venture Studio, Senior Executive Investor-in-Residence for Healthcare at Techstars Powered by J.P. Morgan, Host of the BetterHealth Webinar Series, and contributing writer for Fast Company on healthcare venture capital and entrepreneurship.

 

Over the past 15 years, Endeavor Life Sciences Venture Funds have invested in drug discovery and development, rare diseases, AI driven diagnostics, biomarkers, medical devices, personalized and precision medicine, AI radiology, AI pathology, mental health, and women’s health, and is a strong supporter of women CEOs and CEOs from diverse communities.

Ask Me About:

Innovation
Entrepreneurship
Venture Capital
Leadership

Professional Background

Dr. Martin Alexander Gershon, MD, JD, MPH is the Managing Partner and CIO of Endeavor Life Sciences Venture Funds and Venture Studio, Senior Executive Investor-in-Residence for Healthcare at Techstars Powered by J.P. Morgan, Host of the BetterHealth Webinar Series, and contributing writer for Fast Company on healthcare venture capital and entrepreneurship.He has been honored by Standard and Poor’s as a designated Top 100 “Healthcare Industry Leader”, recognized by Linkedin as a “Top Voice” in Venture Capital and Entrepreneurship, is an award winning Google Scholar in Entrepreneurship, and has been featured on CNBC and in numerous conferences and publications as one of the leading healthcare investors, strategists, futurists and entrepreneurs in drug discovery, biotechnology and AI and digital healthcare. Over the past 23 years he founded 6 startups, lead Endeavor Venture Funds to over 100 investments, has served as Senior Strategic Advisor for Fortune 500 Companies including McKinsey, Goldman Sachs, Bain Capital, BlackRock, American Express, Tiger Global, GlaxoSmithKline, Bristol-Myers Squibb, Pfizer, and Novartis, and has developed Endeavor into a thriving ecosystem of partnerships with BioPharma, Digital Health, and Big Tech companies, world class CEO entrepreneurs, start-up accelerators, and prominent Ivy League universities, medical centers, and business schools like Harvard, Columbia, MIT, NYU, Oxford, McGill and Johns Hopkins.Dr. Gershon is the former Aspen Institute Business of Health Chair and Senior Fellow, Memorial Sloan-Kettering Cancer Center Mayday Fellow, Harvard, McGill and Columbia trained neuroscientist, oncologist and immunologist, Senior Lecturer of Healthcare Economics and Entrepreneurship at Johns Hopkins, Professor of Healthcare Policy and Finance at Columbia, Professor of Healthcare Innovation and Entrepreneurship at McGill, Guest Lecturer of Drug Development and Drug Discovery at Harvard and MIT, Guest Lecturer of Healthcare AI and Digital Innovation and Commercialization at NYU and Johns Hopkins, Executive-in-Residence at Matter Health, Chief Innovation and Investment Officer of Life Sciences at McGill CLIP, Special Advisor to the Dean of the McGill University School of Medicine for licensing and commercialization, and former FDA attorney specializing in clinical trials and drug and device approvals.Endeavor Life Science Venture Funds is a Series B evergreen fund and Seed and Series A Venture Studio and has made over 100 investments in dozens of groundbreaking companies in biotech and AI and digital healthcare companies. Over the past 15 years Endeavor has invested in drug discovery and development, rare diseases, AI driven diagnostics, biomarkers, medical devices, personalized and precision medicine, AI radiology, AI pathology, mental health, and women’s health, and is a strong supporter of women CEOs and CEOs from diverse communities. We invest 100-500K USD initially up to 5M USD in the Venture Studio Companies, and 5-25M USD initially up to 75M USD in the Series B Companies. The Fund also invests in later stage pre-IPO companies who are licensing technology from our portfolio companies.

Search

Login
Join MFN

JOIN MFN!

This content is accessible to MFN members only. Join MFN and get access to this page, plus new resources we’re adding all the time.

Find out how to join MFN here!

MFN Deal Rooms are stored on MFN/Lever Google Workspace. Only the following people will have access to your Deal Room:

 

  1. You and any members of your team that you designate. You will have editing privileges, and can add others with editing privileges at your discretion.
  2. MFN/ Lever staff will have administrative access, but we will not give access to any third parties without your consent.
  3. Investors that you select.

 

Your Deal Room will have all of the security protections provided by Google.

Founders are everywhere, but resources aren’t.

That’s a shame, because the next big idea could come from anywhere.

 

The Massachusetts Founder Network aims to bridge the gap, giving startup founders equitable access to resources that will help their companies grow.

 

We support MA founders no matter where they come from, their company’s stage, or their business sector. We want to democratize access to the resources that will help them accelerate—and excel. All founders are welcome to find resources and community at MFN while creating connections, expanding their networks, and learning from one another.

About MFN

The Massachusetts Founders Network is a central hub for all things startups, fostering innovation and collaboration across the state. MFN offers valuable networking, resources, mentorship, and community for startup founders in Massachusetts. 

 

MFN is produced by Lever, a startup accelerator based in North Adams. Our work is supported by funding from and collaboration with the Massachusetts Technology Collaborative, based in Westborough.

 

We’ve been advising and connecting with entrepreneurs for years, and we’re using that knowledge and network to launch something new, with the help of an advisory board of successful founders and major players in the startup ecosystem. 

We plan to launch the Massachusetts Founders Network in summer 2023. Sign up for our newsletter to get alerts about our launch, new features, and MFN events!